Newsroom

Page Meta: of 97 press releases

Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease

Freeline Reports Updated Data From Phase 1/2 B-AMAZE Trial in Hemophilia B

Freeline appoints Mark Baldry as Chief Commercial Officer

Freeline to present new data at the 12th Annual Protein and Antibody Engineering Summit

Freeline Reports Half Year 2020 Financial Results and Recent Business Highlights

Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference at the revised time of 3.45 pm EDT on 6 October

Freeline announces promotion of Romuald Corbau, Ph.D. to Chief Scientific Officer

Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference

Freeline announces supply agreement for haemophilia B program

Freeline to participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

Freeline Announces Pricing of Initial Public Offering

For all media enquiries please get in touch

media@freeline.life